Adaptive Biotechnologies (ADPT) stock swings after earnings as MRD guidance, insider sale draw scrutiny
Shares of Adaptive Biotechnologies dropped 5.2% to $15.61 Friday afternoon, giving up early gains as enthusiasm over the company’s quarterly results and 2026 outlook faded. The stock’s range for the day ran from $17.69 down to $15.08.